GitLab is not worth investing in because of competition from Microsoft's GitHub, even after a 75% drawdown. AI won't replace the tool, and it has strong switching-cost and brand moats. x.com 

Elevated AI risk makes GitLab a stock not worth being long at $60, despite a personal fair-value estimate at that level. A post by choblin29 reports that Anthropic replaced Git with its own version-control system and built Scion for code review. x.com  x.com 

GitLab's re-accelerating revenue would make a takeover lucrative, and Anthropic again looks like a credible buyer alongside IBM, OpenAI or Cursor/SpaceX. Growing 23% a year through 2027, then selling to a frontier lab for 8-10x revenue, would be a big return; even IBM as a distressed buyer at 5x would pay off, and IBM may need it to survive. The risk is that labs that don't buy will build their own and the Git duopoly is fading, so conviction is not extreme. x.com 

GitLab faces an existential crisis as the AI "SaaSapocalypse" arrives, yet it still trades at 4.7x sales despite decelerating growth and 10+ analyst downgrades in 2026. x.com 

GitLab is poorly placed to exploit GitHub's moment of weakness because its product is too similar to GitHub and in many ways worse. Hands-on testing found poor design: it took minutes to find where to create a repo, and pushing failed because force push to main was disabled. That explains why few are talking about migrating despite the stock's 50%+ fall over the past year. Unless it reinvents the product, it is not worth buying; whatever comes next in source control will look different. x.com  … Show more

GitLab should see some GitHub-to-GitLab migration and excitement, but Duo Agent is unlikely to contribute meaningfully until next quarter, if not later. A post-earnings drop back to where the stock started, as @cryptopunk2020 predicts, would be welcome as a chance at more cheap shares. x.com 

GitLab doesn't justify 65x forward earnings or a 17% post-earnings jump. Gross margin is compressing, possibly structurally, the quarter and guide show little operating leverage, it is still EBIT-negative at a $9.2bn market cap, and guidance appears to point to decelerating growth. x.com 

GitLab's results don't justify the stock's after-hours rise. Expense dollars grew far faster than revenue dollars, 117% net retention is unimpressive at this valuation, and stock-based compensation rose 50% year over year. x.com 

GitLab looks mispriced against the data value implied by xAI's deal for an option to buy Cursor at $60 billion. At about $2.5 billion of enterprise value, GitLab's code data would be worth only around 5% of Cursor's, which is hard to believe; even a weak plan to monetize that data should spark a monster move, and if management won't, another company could acquire GitLab to exploit it. One caveat: a large share of GitLab is self-managed, so that portion cannot be trained on. x.com 

GitLab's restructuring plan earned it an analyst downgrade. x.com